The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Aimed at young professional working in solid organ transplant, this Masterclass will provide crucial insight into the cutting-edge technologies that are about to revolutionise the transplantation field, including cell-free DNA, new plasma, urinary and immune function biomarkers, gene-expression profiling, as well as recent advances on HLA and non-HLA antibodies.
This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
ETAHP (The European Transplant Allied Healthcare Professionals) is thrilled to announce a new online course on post-transplant rehabilitation. This course provides transplant professionals with the tools necessary to support patient recovery after transplantation through a team-based approach. The first three modules address the foundations of person-centred care, physical activity and exercise, and psychosocial well-being. The patient perspective is
ETAHP – The European Transplant Allied Healthcare Professionals – would like to announce a call for nominations for a new Board member. The new ETAHP Board Member will hold office for 4 years (2024-2028). All ESOT/ETAHP affiliates are welcome to send nominations for these positions. You may nominate yourself or a colleague. In addition, considering the specialities
Don’t miss the opportunity to join renowned experts in the field as they delve into the implications of xenotransplantation including inequity of access, ethical dilemmas, societal consequences and religious connotations…
Join us on 19 September at 20:00 EEST at this unmissible congress session.
ETAHP – The European Transplant Allied Healthcare Professionals – would like to announce a call for nominations for two new Board members. The new ETAHP Board Members will hold office for 4 years (2023-2027), starting at the ESOT Congress, September 2023. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. You may nominate
ELPAT – The European Platform on Ethical, Legal and Psychosocial Aspects of Organ Transplantation – would like to announce a call for nominations for new members of the following Expert Working Groups: Public Issues Working Group – 1 position available. Living Organ Donation Working Group – 3 positions available. This group encourages applications from nephrologists,
We are delighted to announce that the deadline to apply as an ETAHP board member has been extended: the new deadline is 4 December 2022. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. In addition, you may nominate yourself or a colleague. The new ETAHP Board Members will hold office for four
The European Transplant Allied Healthcare Professionals (ETAHP) – would like to announce a call for nominations for two new Board members. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. You may nominate yourself or a colleague. The new ETAHP Board Members will hold office for 4 years (2022-2026), starting December 2022. In
We would like to announce a call for nominations for four new Board members. ESOT/VCA affiliates are eligible to submit their application for the positions. The intention of the ESOT VCA Section is to foster the scientific and clinical development of Vascularized Composite Allotransplantation in Europe and to serve as a platform for scientists and
